Table 1.
Differences between HIV-positive patients with “anti-HBc alone” and past hepatitis B
| “anti-HBc alone” pattern (n = 55) | Past hepatitis B (n = 55) | P | |
| Age, yr | 38 (33-43) | 45 (37-49) | 0.001 |
| Male, n (%) | 38 (69.1) | 38 (69.1) | 1.000 |
| Transmission mode n (%) | 0.021 | ||
| IDU | 44 (80) | 34 (61.8) | |
| Homosexual | 4 (7.3) | 15 (27.3) | |
| Heterosexual | 7 (7.7) | 6 (10.9) | |
| AST (IU/mL) | 43 (23-65) | 31 (22-47) | 0.092 |
| ALT (IU/mL) | 39 (19-73) | 29 (20-45) | 0.301 |
| Albumin (g/L) | 42 (38.8-45.6) | 43 (40.8-45.9) | 0.261 |
| Anti-HCV positive, n (%) | 45 (81.8) | 34 (61.8) | 0.020 |
| CDC C stage, n (%) | 15 (27.3) | 19 (34.5) | 0.409 |
| CD4 (cells/mm3) | 434 (325-714) | 459 (303-636) | 0.740 |
| HIV DNA < 50 copies/mL | 25 (47.2) | 32 (59.3) | 0.210 |
IDU: Intravenous drug user; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.